参与慢性免疫血小板缩的体育运动:比你想象的更安全吗?
Char M Witmer1, Michele P Lambert1
1Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Pediatric blood & cancer
|September 21, 2023
概括
患有慢性免疫血栓塞缩症 (ITP) 的儿童通常可以安全地参加体育运动. 伤害风险与高风险运动有关,而不是一般活动,这表明大多数儿科ITP患者可以参与游戏.
科学领域:
- 儿科血液学 儿科血液学
- 运动医学 运动医学
- 临床儿科 临床儿科
背景情况:
- 儿童的慢性免疫血小板缺血症 (ITP) 通常导致活动限制.
- 关于活动限制的临床决定缺乏支持数据.
- 确定儿科慢性ITP中受伤风险因素至关重要.
研究的目的:
- 确定患有慢性ITP的儿科患者受伤相关的风险因素.
- 评估慢性ITP儿童参加体育运动的安全性.
主要方法:
- 回顾性单中心队列研究.
- 包括患有慢性ITP (5-21岁) 的儿科患者 (血小板计数<100,000/μL>1年).
- 在平均3.8年的随访期间分析了受伤数据.
主要成果:
- 包括102名受试者;60%参加了有组织的体育活动.
- 在26名受试者中发生了31起伤害,大多数是轻微的 (软组织,头部创伤) 和在游戏期间.
- 与高风险运动 (p < .001),男性性别 (p = .007) 和多项运动 (p = .008) 相关的受伤风险.
结论:
- 儿科慢性ITP患者的受伤程度轻微且不常见.
- 大多数孩子都安全地参加有组织的体育运动.
- 参与高风险运动是这一群体中受伤的主要风险因素.
相关概念视频
Pulmonary Tuberculosis I
257
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
257
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Disorders of Hemostasis
982
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
982
Myocarditis III: Medical Management
7
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
7
Chronic Kidney Disease II: Clinical Manifestations
16
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
16
Blood Transfusion and Agglutination
10.9K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.9K


